Skip to main content
. Author manuscript; available in PMC: 2021 Feb 5.
Published in final edited form as: ALTEX. 2020 Feb 28;37(3):365–394. doi: 10.14573/altex.2001241

Fig. 3: The US tissue chip program at a glance.

Fig. 3:

This FDA-DARPA-NIH MPS-based program aimed at developing in vitro platforms that use human tissues to evaluate the efficacy, safety and toxicity of promising therapies (adopted from Smirnova et al., 2018).